
Kiora Pharmaceuticals Inc
KPRXNasdaqCIK 1372514HealthcareFiscal year ends Dec 31
Reports and events: 268 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-04-1509:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001410578-22-000925 |
| 2022-03-2317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-037086 |
| 2022-02-2816:30 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001104659-22-028121 |
| 2022-02-1417:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-023200 |
| 2022-02-0106:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-010000 |
| 2022-01-1117:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-002825 |
| 2021-12-1507:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-149776 |
| 2021-12-1407:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-149386 |
| 2021-11-1507:30 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001410578-21-000215 |
| 2021-11-0807:32 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-135333 |
| 2021-10-2607:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-129738 |
| 2021-09-1416:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-115504 |
| 2021-08-2616:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-109807 |
| 2021-08-1216:19 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001104659-21-104182 |
| 2021-08-1006:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-102512 |
| 2021-08-0406:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-099777 |
| 2021-08-0317:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001011438-21-000187 |
| 2021-07-2616:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-095852 |
| 2021-06-2516:31 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-085746 |
| 2021-05-2707:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-072696 |
| 2021-05-1216:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001104659-21-065128 |
| 2021-04-3016:05 ET | DEF 14A | Proxy statementPeriod 2021-06-24 | 0001104659-21-058990 |
| 2021-04-0106:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-045169 |
| 2021-03-2516:16 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001104659-21-041515 |
| 2021-03-0516:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-21-032744 |
| 2021-02-0106:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-009669 |
| 2021-01-1217:08 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-21-000243 |
| 2021-01-0606:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-001243 |
| 2020-12-2106:55 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-137679 |
| 2020-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001104659-20-123064 |
| 2020-09-1406:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-104579 |
| 2020-08-0616:15 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001104659-20-091445 |
| 2020-06-2616:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-20-077470 |
| 2020-06-0106:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-067975 |
| 2020-05-0616:16 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001104659-20-057438 |
| 2020-04-2916:14 ET | DEF 14A | Proxy statementPeriod 2020-06-25 | 0001104659-20-053380 |
| 2020-03-3106:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-040798 |
| 2020-03-2416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-20-037762 |
| 2020-03-0416:16 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001104659-20-029162 |
| 2020-01-1516:46 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-20-000369 |
| 2020-01-1016:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-20-003056 |
| 2020-01-1016:07 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-20-000308 |
| 2020-01-0317:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-20-000963 |
| 2019-12-3116:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-077311 |
| 2019-12-1708:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-073250 |
| 2019-12-0306:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-19-069209 |
| 2019-12-0206:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-068757 |
| 2019-11-2206:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-19-066395 |
| 2019-11-0708:31 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001104659-19-060851 |
| 2019-10-1816:36 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-19-006500 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:43 ET. Listed shows no prices and gives no investment advice.